$31.99 0.09 (+0.28%)
2/13/2012 4:00 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

3
Player Avatar manchesteruk (< 20) Submitted: 10/5/2006 3:30:14 AM : Underperform Start Price: $19.13 BMY Score: -60.76

only potential M&A make this stock attractive

Report this Post 1 Comment
Member Avatar johnsloan (96.85) Submitted: 11/2/2006 12:17:54 PM
Recs: 0

that is a big attraction

Featured Broker Partners


Advertisement